![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1564011
¼¼°èÀÇ ½ÉÀå ¸ð´ÏÅ͸µ ¹× ½ÉÀå ¹Úµ¿ °ü¸® ±â±â ½ÃÀåCardiac monitoring & cardiac rhythm management devices |
½ÉÀå ¸ð´ÏÅ͸µ ¹× ½ÉÀå ¹Úµ¿ °ü¸® ÀåÄ¡ ¼¼°è ½ÃÀåÀº 2030³â±îÁö 382¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù
2023³â 291¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ½ÉÀå ¸ð´ÏÅ͸µ ¹× ½ÉÀå ¹Úµ¿ °ü¸® ±â±â ¼¼°è ½ÃÀåÀº 2030³â 382¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2023-2030³âÀÇ ºÐ¼® ±â°£ µ¿¾È 4.0%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ º¸°í¼¿¡¼ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ ½ÉÀüµµ(ECG) ±â±â´Â CAGR 3.8%¸¦ ±â·ÏÇÏ¸ç ºÐ¼® ±â°£ Á¾·á ½ÃÁ¡¿¡ 245¾ï ´Þ·¯¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. À̽ÄÇü ·çÇÁ ·¹ÄÚ´õ(ILR) ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 4.3%·Î ÃßÁ¤µË´Ï´Ù.
¹Ì±¹ ½ÃÀåÀº 79¾ï ´Þ·¯, Áß±¹Àº CAGR 3.8%·Î ¼ºÀå Àü¸Á
¹Ì±¹ÀÇ ½ÉÀå ¸ð´ÏÅ͸µ ¹× ½ÉÀå ¹Úµ¿ °ü¸® ±â±â ½ÃÀåÀº 2023³â 79¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2023-2030³â ¿¬Æò±Õ 3.8%ÀÇ ¼ºÀå·üÀ» º¸À̸ç 2030³â¿¡´Â 61¾ï ´Þ·¯ ±Ô¸ð¿¡ À̸¦ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ´Ù¸¥ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ª ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ µ¿¾È °¢°¢ 3.8%¿Í 3.2%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)À» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. À¯·´¿¡¼´Â µ¶ÀÏÀÌ ¾à 4.1%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
¼¼°è ½ÉÀå ¸ð´ÏÅ͸µ ¹× ½ÉÀå ¹Úµ¿ ¸®µë °ü¸® ±â±â ½ÃÀå - ÁÖ¿ä µ¿Çâ ¹× ÃËÁø¿äÀÎ ¿ä¾à
½ÉÀå ¸ð´ÏÅ͸µ ¹× ½ÉÀå ¸®µë °ü¸® ÀåÄ¡¶õ ¹«¾ùÀΰ¡?
½ÉÀå ¸ð´ÏÅ͸µ ¹× ½ÉÀå ¸®µë °ü¸®(CRM) ±â±â´Â Çö´ë ÀÇ·á, ƯÈ÷ Àü ¼¼°è »ç¸Á ¿øÀÎ 1À§ÀÎ ½ÉÇ÷°ü ÁúȯÀ» Áø´ÜÇÏ°í °ü¸®ÇÏ´Â µ¥ ÇʼöÀûÀÎ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ÀÌ ±â±âµéÀº ½ÉÀå ¸®µë Àå¾Ö¸¦ °¨ÁöÇϰí Ä¡·áÇÏ´Â µ¥ »ç¿ëµÇ¸ç, ȯÀÚ°¡ ±ÔÄ¢ÀûÀÎ ½ÉÀå ¹Úµ¿À» À¯ÁöÇÏ°í ³úÁ¹ÁßÀ̳ª ½ÉÀå µ¹¿¬»ç¿Í °°Àº ½É°¢ÇÑ °á°ú¸¦ ÇÇÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù. ȦÅÍ ¸ð´ÏÅÍ, À̺¥Æ® ·¹ÄÚ´õ, ½ÉÀüµµ(ECG)¿Í °°Àº ½ÉÀå ¸ð´ÏÅ͸µ ÀåÄ¡´Â ÁÖ·Î Áø´Ü µµ±¸·Î, ȯÀÚÀÇ ½ÉÀå Ȱµ¿À» Àå±âÀûÀ¸·Î ÃßÀûÇϰí Á¤±âÀûÀÎ ÀÓ»ó °Ë»ç·Î´Â ¹ß°ßÇÒ ¼ö ¾ø´Â ºÎÁ¤¸Æ°ú °°Àº ÀÌ»óÀ» ½Äº°ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÇÑÆí, ½É¹ÚÁ¶À²±â ¹× À̽ÄÇü Á¦¼¼µ¿±â(ICD)¿Í °°Àº CRM ÀåÄ¡´Â ½ÉÀå ¸®µëÀ» ¸ð´ÏÅ͸µÇÒ »Ó¸¸ ¾Æ´Ï¶ó ºÎÁ¤¸ÆÀ» ±³Á¤Çϱâ À§ÇØ Àü±â ÀÚ±ØÀ» °ø±ÞÇÏ¿© ½ÉÀå ¸®µëÀ» °ü¸®Çϰí Ä¡·áÇÏ´Â µ¥ »ç¿ëµË´Ï´Ù. ÀÌ ÀåÄ¡´Â ½ÉÀå ¸®µëÀÌ À§ÇèÇÒ Á¤µµ·Î ºÒ±ÔÄ¢ÇØÁ³À» ¶§ °³ÀÔÇÏ¿© Á¤»óÀûÀÎ ½ÉÀå ¹Úµ¿À» ȸº¹Çϵµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù. ¼ö³â µ¿¾È ÀÌ·¯ÇÑ ±â¼úÀº ¸¸¼º ½ÉÇ÷°ü Áúȯ ȯÀÚÀÇ Ä¡·á ǰÁúÀ» Å©°Ô Çâ»ó½ÃÄÑ »ý¸íÀ» À§ÇùÇÏ´Â ½ÉÀå ÁúȯÀ» ´Ü±âÀûÀ¸·Î Áø´ÜÇϰí Àå±âÀûÀ¸·Î °ü¸®ÇÒ ¼ö ÀÖ°Ô Çß½À´Ï´Ù.
½ÉÀå ¸ð´ÏÅ͸µ ¹× ¸®µë °ü¸® ±â¼úÀº ¾î¶»°Ô ¹ßÀüÇϰí Àִ°¡?
½ÉÀå ¸ð´ÏÅ͸µ ¹× CRM ±â±âÀÇ ±â¼ú Çõ½ÅÀº ±â´É, Á¤È®¼º ¹× ȯÀÚ °æÇèÀ» ȹ±âÀûÀ¸·Î °³¼±Çß½À´Ï´Ù. °¡Àå Áß¿äÇÑ ¹ßÀü Áß Çϳª´Â ȯÀڷκÎÅÍ ÀÇ·á ¼ºñ½º Á¦°ø¾÷ü¿¡°Ô ½Ç½Ã°£À¸·Î µ¥ÀÌÅ͸¦ Àü¼ÛÇÒ ¼ö ÀÖ´Â ¹«¼± ¿ø°Ý ¸ð´ÏÅ͸µ ±â´ÉÀÇ °³¹ßÀÔ´Ï´Ù. À̸¦ ÅëÇØ ÀÓ»óÀǰ¡ ¿ø°ÝÀ¸·Î ½ÉÀå ¸®µëÀ» Áö¼ÓÀûÀ¸·Î ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖ°Ô µÊ¿¡ µû¶ó, Áø·á½ÇÀ» ÀÚÁÖ ¹æ¹®ÇÒ Çʿ䰡 ÁÙ¾îµé¾î ½ÉÀå Ä¡·á¿¡ Çõ¸íÀ» ÀÏÀ¸Ä×½À´Ï´Ù. ÷´Ü ½É¹Ú¼ö ¼¾¼°¡ žÀçµÈ ¿þ¾î·¯ºí ½ÉÀüµµ ¸ð´ÏÅÍ¿Í ½º¸¶Æ®¿öÄ¡¿Í °°Àº ±â±â´Â ½ÉÀå ¸ð´ÏÅ͸µÀ» ´õ¿í Ä£¼÷ÇÏ°Ô ¸¸µé¾î ÀÏ»ó »ýȰ¿¡¼ ½ÉÀå °Ç° »óŸ¦ Áö¼ÓÀûÀ¸·Î ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖ°Ô Çß½À´Ï´Ù. ¿ÜºÎ ¸ð´ÏÅÍ ¿Ü¿¡µµ ½É¹ÚÁ¶À²±â³ª Á¦¼¼µ¿±â¿Í °°Àº À̽ÄÇü ÀåÄ¡µµ ±â¼úÀû Áøº¸¸¦ °ÅµìÇϰí ÀÖ½À´Ï´Ù. ÀÌµé ±â±âÀÇ ÃֽйöÀüÀº ´õ ÀÛ°í, ´õ È¿À²ÀûÀ̸ç, ´õ ¿À·¡ Áö¼ÓµÇ±â ¶§¹®¿¡ ¼ö¼úÀû ±³Ã¼°¡ ´ú ÇÊ¿äÇÏ°Ô µÇ¾ú½À´Ï´Ù. ¶ÇÇÑ ÀΰøÁö´É(AI)°ú ¸Ó½Å·¯´× ¾Ë°í¸®ÁòÀÌ ÀÌ·¯ÇÑ ½Ã½ºÅÛ¿¡ ÅëÇÕµÇ¾î ºÎÁ¤¸ÆÀÌ ½É°¢ÇÑ ¹®Á¦·Î ¹ßÀüÇϱâ Àü¿¡ ºÎÁ¤¸Æ ÆÐÅÏÀ» ½Äº°ÇÒ ¼ö ÀÖ´Â ¿¹Ãø ºÐ¼®ÀÌ °¡´ÉÇØÁ³½À´Ï´Ù. ÀÌ´Â º¸´Ù Àû±ØÀûÀÎ ½ÉÀå Ä¡·áÀÇ ±æÀ» ¿¾î ¼Ò±ØÀû Ä¡·á¿¡¼ ȯÀÚÀÇ ¿¹Èĸ¦ °³¼±ÇÏ´Â ¿¹¹æÀû Àü·«À¸·Î ÀüȯÇϰí ÀÖ½À´Ï´Ù. ±â¼úÀÌ ¹ßÀüÇÔ¿¡ µû¶ó ¿þ¾î·¯ºí ±â¼ú, AI, ¿ø°Ý ÀÇ·á°¡ À¶ÇÕµÇ¾î ½ÉÀå ¸ð´ÏÅ͸µ ¹× ¸®µë °ü¸® ±â´ÉÀÌ Å©°Ô Çâ»óµÇ°í ÀÖ½À´Ï´Ù.
½ÉÀå ¸ð´ÏÅ͸µ ¹× ¸®µë °ü¸®ÀÇ ÁÖ¿ä ½ÃÀå µ¿ÇâÀº?
Àα¸ Åë°èÇÐÀû º¯È, ÀÇ·á ¼ºñ½º Á¦°øÀÇ º¯È, ÀÇ·á ±â¼úÀÇ ¹ßÀüÀ¸·Î ÀÎÇØ ¸î °¡Áö ÁÖ¿ä Æ®·»µå°¡ ½ÉÀå ¸ð´ÏÅ͸µ ¹× ¸®µë °ü¸® ½ÃÀåÀ» Çü¼ºÇϰí ÀÖ½À´Ï´Ù. Àα¸ °í·ÉÈ, °Ç°¿¡ ÇØ·Î¿î »ýȰ ½À°ü, °íÇ÷¾Ð, ´ç´¢º´ ¹× ºñ¸¸ Áõ°¡¿Í °°Àº ¿äÀÎÀ¸·Î ÀÎÇÑ ½ÉÇ÷°ü ÁúȯÀÇ À¯º´·ü Áõ°¡´Â ÀÌ·¯ÇÑ Àåºñ¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃËÁøÇÏ´Â ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù. Àα¸°¡ °í·Éȵʿ¡ µû¶ó ƯÈ÷ ³ëÈ¿Í °ü·ÃµÈ ½ÉÇ÷°ü°è ÁúȯÀÌ º¸Æíȵʿ¡ µû¶ó Áö¼ÓÀûÀÌ°í ½Å·ÚÇÒ ¼ö ÀÖ´Â ½ÉÀå ¸ð´ÏÅ͸µÀÇ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¶Ç ´Ù¸¥ ÁÖ¿ä Æ®·»µå´Â ȯÀÚ Áß½ÉÀÇ ÀÇ·á ¼ºñ½º·ÎÀÇ ÀüȯÀ¸·Î, Áö¼ÓÀûÀÎ ½ÉÀå ¸ð´ÏÅ͸µÀ» °¡´ÉÇÏ°Ô ÇÏ´Â ¿þ¾î·¯ºí ±â¼úÀ» ÅëÇØ ÀÚ½ÅÀÇ °Ç° °ü¸®¿¡ Àû±ØÀûÀÎ ¿ªÇÒÀ» ÇÏ´Â °³ÀÎÀÌ Áõ°¡Çϰí ÀÖÀ¸¸ç, ECG ±â´ÉÀÌ Å¾ÀçµÈ ½º¸¶Æ®¿öÄ¡¿Í °°Àº ÀåÄ¡´Â ħ½ÀÀû ½Ã¼ú ¾øÀ̵µ Á¤±âÀûÀ¸·Î ½ÉÀå °Ç°À» ¸ð´ÏÅ͸µÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù. ħ½ÀÀû ½Ã¼ú ¾øÀÌ Á¤±âÀûÀ¸·Î ½ÉÀå °Ç° »óŸ¦ ¸ð´ÏÅ͸µÇϰíÀÚ ÇÏ´Â ¼ÒºñÀÚµé »çÀÌ¿¡¼ Àα⸦ ¾ò°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ °³ÀÎÈµÈ ÀÇ·á ¼ºñ½º·ÎÀÇ ÀüȯÀº ¿ø°Ý ÀÇ·áÀÇ ºÎ»ó°ú ÇÔ²² ¿ø°Ý ½ÉÀå ¸ð´ÏÅ͸µ ¼Ö·ç¼ÇÀÇ º¸±ÞÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÀÇ·á ¼ºñ½º Á¦°ø¾÷üµéÀº ƯÈ÷ Á¶±â ¹ß°ß°ú °³ÀÔÀ» ÅëÇØ º´¿ø ÀçÀÔ¿øÀ» ÁÙÀ̰í ȯÀÚ °á°ú¸¦ °³¼±Çϱâ À§ÇØ ÀÌ·¯ÇÑ ±â¼úÀ» ¼ö¿ëÇϰí ÀÖ½À´Ï´Ù. ±ÔÁ¦ ±â°ü°ú º¸Çè»çµéµµ ÀÌ·¯ÇÑ ±â±âÀÇ »ç¿ëÀ» Áö¿øÇϱâ À§ÇØ »óȯ Á¤Ã¥À» È®´ëÇϱ⠽ÃÀÛÇßÀ¸¸ç, À̴ ȯÀڵ鿡°Ô ÀÌ·¯ÇÑ ±â¼úÀ» ´õ¿í ½±°Ô ÀÌ¿ëÇÒ ¼ö ÀÖµµ·Ï ÇÏ¿© ½ÃÀå ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.
½ÉÀå ¸ð´ÏÅ͸µ ¹× ¸®µë °ü¸® ±â±â ½ÃÀåÀÇ ÁÖ¿ä ¼ºÀå ÃËÁø¿äÀÎÀº ¹«¾ùÀΰ¡?
½ÉÀå ¸ð´ÏÅ͸µ ¹× ½ÉÀå ¹Úµ¿ °ü¸® ±â±â ½ÃÀåÀÇ ¼ºÀåÀº ±â¼ú ¹ßÀü, ÀÇ·á ȯ°æÀÇ º¯È, ¼ÒºñÀÚ ÇൿÀÇ º¯È¿Í Á÷°áµÇ´Â ¸î °¡Áö ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ¿ì¼±, AI¸¦ Ȱ¿ëÇÑ ¿¹Ãø ºÐ¼®, À̽ÄÇü ÀåÄ¡ÀÇ ¼ÒÇüÈ, ¹èÅ͸® ¼ö¸í Çâ»ó°ú °°Àº ±â¼ú Çõ½ÅÀº ½ÉÀå ¸®µëÀ» º¸´Ù Á¤È®ÇÏ°Ô ¸ð´ÏÅ͸µÇϰí ÀáÀçÀûÀÎ ¹®Á¦°¡ ½É°¢ÇØÁö±â Àü¿¡ ȯÀÚ¿Í ÀÓ»óÀÇ¿¡°Ô °æ°í¸¦ º¸³¾ ¼ö ÀÖ´Â AI¸¦ ÅëÇØ ÀÌ·¯ÇÑ ÀåÄ¡¸¦ ´õ¿í ¸Å·ÂÀûÀ̰í È¿°úÀûÀ¸·Î ¸¸µé°í ÀÖ½À´Ï´Ù. °æ°íÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ »çÈÄ ´ëÀÀÀÌ ¾Æ´Ñ ¿¹ÃøÀû ÀÇ·á ¼ºñ½º·ÎÀÇ ÀüȯÀº Å« ¼¼ÀÏÁî Æ÷ÀÎÆ®°¡ µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ±â±âÀÇ ¼ÒÇüÈ·Î ÀÎÇØ ½É¹ÚÁ¶À²±â³ª Á¦¼¼µ¿±â¿Í °°Àº À̽ÄÇü ¼Ö·ç¼ÇÀº ´ú ħ½ÀÀûÀ̰í, ȯÀÚ¿¡°Ô ´õ Æí¾ÈÇϸç, ±³Ã¼ÇÒ ÇÊ¿ä ¾øÀÌ ´õ ¿À·¡ ÀÛµ¿ÇÒ ¼ö ÀÖ¾î ȯÀÚÀÇ ¼øÀÀµµ¿Í Æí¾ÈÇÔÀ» Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù. Áö¼ÓÀûÀÎ ºñħ½ÀÀû ¸ð´ÏÅ͸µÀ» Á¦°øÇÏ´Â ¿þ¾î·¯ºí ±â±â¿¡ ´ëÇÑ ¼ÒºñÀÚ ¼±È£µµ°¡ ³ô¾ÆÁö¸é¼ ½ÃÀå ¼ºÀå¿¡ ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. ½ÉÀå °Ç°¿¡ ´ëÇÑ ½Ç½Ã°£ µ¥ÀÌÅ͸¦ Á¦°øÇÏ´Â ½º¸¶Æ® ¿öÄ¡³ª ÆÐÄ¡¸¦ ¼±ÅÃÇÏ´Â »ç¶÷µéÀÌ ´Ã°í Àֱ⠶§¹®ÀÔ´Ï´Ù. ¿ø°Ý ÀÇ·á Áõ°¡·Î ÀÎÇØ ¿ø°Ý ¸ð´ÏÅ͸µÀÌ ÇコÄɾ ÇʼöÀûÀÎ ¿ä¼Ò·Î ÀÚ¸® ÀâÀ¸¸é¼ ´õ ¸¹Àº ȯÀÚ¿Í ÀÇ·á ¼ºñ½º Á¦°ø¾÷ü°¡ ÀÌ·¯ÇÑ ±â¼úÀ» äÅÃÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ³ëÀεéÀº Àå±âÀûÀÎ ¸ð´ÏÅ͸µ°ú °³ÀÔÀÌ ÇÊ¿äÇÑ ½ÉÀå Áúȯ¿¡ °É¸®±â ½±±â ¶§¹®¿¡ Àü ¼¼°è Àα¸ÀÇ °í·Éȵµ Å« ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Àü ¼¼°è ÀÇ·á ½Ã½ºÅÛÀº ȯÀÚ ¿¹Èĸ¦ °³¼±ÇÏ°í ºñ¿ëÀ» Àý°¨ÇÏ´Â °ÍÀÌ Áß¿äÇÑ ¸ñÇ¥ÀÎ °¡Ä¡ ±â¹Ý Áø·á¿¡ Á¡Á¡ ´õ ¸¹Àº ÃÊÁ¡À» ¸ÂÃß¾ú½À´Ï´Ù. ½ÉÀå ¸ð´ÏÅ͸µ ¹× ¸®µë °ü¸® ÀåÄ¡´Â ÀÀ±Þ °³ÀÔ°ú ÀÔ¿øÀÇ Çʿ伺À» ÁÙÀÓÀ¸·Î½á ÀÌ·¯ÇÑ ¸ñÇ¥¸¦ ´Þ¼ºÇÏ´Â µ¥ µµ¿òÀÌ µÇ¸ç, ¸¸¼º ½ÉÀå Áúȯ °ü¸®¿¡ ºñ¿ë È¿À²ÀûÀÎ ¼Ö·ç¼ÇÀ» Á¦°øÇÕ´Ï´Ù. ƯÈ÷ ½ÅÈï±¹¿¡¼´Â ±ÔÁ¦ ´ç±¹ÀÇ ¿ìÈ£ÀûÀÎ Á¤Ã¥À¸·Î ÀÎÇØ ½Å±â¼úÀÇ ½ÂÀÎ ÀýÂ÷°¡ ´õ¿í °£¼ÒÈµÇ¾î ½ÃÀå ÁøÀÔ°ú º¸±ÞÀÌ ´õ¿í »¡¶óÁö°í ÀÖ½À´Ï´Ù.
Global Cardiac monitoring & cardiac rhythm management devices Market to Reach US$38.2 Billion by 2030
The global market for Cardiac Monitoring & Cardiac Rhythm Management Devices estimated at US$29.1 Billion in the year 2023, is expected to reach US$38.2 Billion by 2030, growing at a CAGR of 4.0% over the analysis period 2023-2030. Electrocardiogram (ECG) Devices, one of the segments analyzed in the report, is expected to record a 3.8% CAGR and reach US$24.5 Billion by the end of the analysis period. Growth in the Implantable Loop Recorder (ILRs) segment is estimated at 4.3% CAGR over the analysis period.
The U.S. Market is Estimated at US$7.9 Billion While China is Forecast to Grow at 3.8% CAGR
The Cardiac monitoring & cardiac rhythm management devices market in the U.S. is estimated at US$7.9 Billion in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$6.1 Billion by the year 2030 trailing a CAGR of 3.8% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.8% and 3.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.1% CAGR.
Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market - Key Trends and Drivers Summarized
What Exactly Are Cardiac Monitoring & Cardiac Rhythm Management Devices?
Cardiac monitoring and cardiac rhythm management (CRM) devices have become indispensable in modern healthcare, particularly in diagnosing and managing cardiovascular diseases, which are a leading cause of death worldwide. These devices are used to detect and treat heart rhythm disorders, helping patients maintain regular heartbeats and avoiding severe outcomes such as strokes or sudden cardiac death. Cardiac monitoring devices, like Holter monitors, event recorders, and electrocardiograms (ECG), are primarily diagnostic tools that help track a patient’s heart activity over time, identifying abnormalities such as arrhythmias, which may not be detected during a routine clinical visit. On the other hand, CRM devices, such as pacemakers and implantable cardioverter-defibrillators (ICDs), are not only used to monitor heart rhythms but also to manage and treat them by delivering electrical impulses to correct irregularities. These devices are designed to intervene when the heart's rhythm becomes dangerously irregular, restoring a normal heartbeat. Over the years, these technologies have significantly improved the quality of care for patients with chronic cardiovascular conditions, allowing for both short-term diagnosis and long-term management of life-threatening heart issues.
How Is Technology Evolving in Cardiac Monitoring & Rhythm Management?
Technological innovation in cardiac monitoring and CRM devices has dramatically improved their functionality, accuracy, and patient experience. One of the most significant advancements is the development of wireless, remote monitoring capabilities that allow real-time data transmission from patients to healthcare providers. This has revolutionized cardiac care by reducing the need for frequent clinic visits, enabling clinicians to monitor heart rhythms continuously and remotely. Devices like wearable ECG monitors and smartwatches equipped with sophisticated heart rate sensors have made cardiac monitoring more accessible, allowing for constant monitoring of heart health in day-to-day life. In addition to external monitors, implantable devices like pacemakers and defibrillators have also undergone technological advancements. Modern versions of these devices are smaller, more efficient, and last longer, reducing the need for surgical replacements. Furthermore, artificial intelligence (AI) and machine learning algorithms are now being integrated into these systems, enabling predictive analytics that can identify irregular heart patterns before they escalate into serious problems. This has paved the way for more proactive cardiac care, shifting from reactive treatments to preventative strategies that improve patient outcomes. As the technology continues to advance, we are seeing a convergence of wearable tech, AI, and remote healthcare, significantly enhancing the capabilities of cardiac monitoring and rhythm management.
What Are the Key Market Trends in Cardiac Monitoring & Rhythm Management?
Several key trends are shaping the cardiac monitoring and rhythm management market, driven by demographic changes, shifts in healthcare delivery, and advancements in medical technology. The increasing prevalence of cardiovascular diseases, driven by factors like aging populations, unhealthy lifestyles, and rising incidences of hypertension, diabetes, and obesity, is a primary driver of demand for these devices. As populations grow older, the need for continuous and reliable heart monitoring increases, particularly as age-related cardiovascular issues become more common. Another significant trend is the shift towards patient-centric healthcare, with a growing number of individuals taking active roles in managing their health through wearable technologies that allow for continuous heart monitoring. Devices such as smartwatches with ECG capabilities have gained popularity among consumers who seek to monitor their heart health regularly without invasive procedures. This shift towards personalized healthcare, combined with the rise of telemedicine, has encouraged more widespread adoption of remote cardiac monitoring solutions. Additionally, healthcare providers are embracing these technologies as they seek to reduce hospital readmissions and improve patient outcomes, especially through early detection and intervention. Regulatory bodies and insurance companies have also begun to support the use of these devices by expanding reimbursement policies, making these technologies more accessible to patients, and further boosting market growth.
What Are the Key Growth Drivers in the Cardiac Monitoring & Rhythm Management Devices Market?
The growth in the cardiac monitoring and cardiac rhythm management devices market is driven by several factors directly linked to advancements in technology, shifting healthcare dynamics, and evolving consumer behavior. First and foremost, technological innovations such as AI-driven predictive analytics, miniaturization of implantable devices, and enhanced battery life are making these devices more appealing and effective. AI enables devices to monitor heart rhythms more accurately and alert both patients and clinicians to potential problems before they become critical. This shift towards predictive, rather than reactive, healthcare is becoming a major selling point. Furthermore, the miniaturization of devices has made implantable solutions like pacemakers and defibrillators less invasive, more comfortable for patients, and capable of functioning longer without needing replacement, thus enhancing patient compliance and comfort. The increasing consumer preference for wearable devices that offer continuous, non-invasive monitoring has also spurred market growth, as more people opt for smartwatches and patches that provide real-time data on heart health. The rise in telemedicine has made remote monitoring an integral part of healthcare, encouraging more patients and providers to adopt these technologies. Additionally, the aging global population is a significant driver, as older adults are more prone to heart conditions requiring long-term monitoring and intervention. Moreover, healthcare systems worldwide are increasingly focusing on value-based care, where improving patient outcomes and reducing costs are key objectives. Cardiac monitoring and rhythm management devices help achieve these goals by reducing the need for emergency interventions and hospitalizations, thus offering a cost-effective solution for managing chronic heart conditions. Favorable regulatory policies, particularly in developed regions, have further streamlined the approval process for new technologies, encouraging faster market entry and wider adoption.
Select Competitors (Total 47 Featured) -